The Company


echGraftys was incepted in 2005 by three business-driven executives of the orthopedic industry and an academic Research Director in the field of synthetic biomaterials, leading a renowned Research Unit in Nantes. The Company is headed by Aurélien Valet, CEO and Chairman, a seasoned pharma and biot entrepreneur.

Graftys has implemented a hybrid business model combining a worldwide commercial activity and a strong R&D platform in liaison with the French Academic Research.

Graftys’ mission is to become a major player in the design, manufacturing and commercialization of synthetic bone biomaterials.

To achieve that goal, Graftys has developed an innovation-driven growing pipeline through partnerships with leading academic research institutions in Europe and has progressively built a portfolio aimed at addressing specific and unmet patients’ medical needs. Graftys commercializes its first generation of products in more than 25 countries, including the United States.


Aurélien Valet

Founder & CEO

After graduating with a degree in Marketing and International Business, Aurélien Valet gained experience in medical devices at Cornéal Laboratories (intraocular lenses). Then he focused on the design and management of editorial content of websites before embarking in GRAFTYS venture in 2005. He was one of the founders of the company and held various management positions and became Chief Operating Officer in 2009.

Jean-Michel Bouler

Founder & scientific consultant

Jean-Michel Bouler was appointed as full-Professor in the Department of Materials Science (Dental College – University of Nantes) in September 2005. Then, Prof. Bouler has been running the “Biomat Research Group” for 10 years within an INSERM research unit. He recently joined a new CNRS research center to focus on the synthesis and characterization of drug-combination systems based on calcium phosphate biomaterials. Jean-Michel Bouler has been consulting for orthopaedics companies for more than 20 years and co-founded Graftys in 2005.

Alain Valet

Founder & strategy consultant

Alain Valet was one of four founders of Graftys. Prior to this, Alain had a successful career in the medical device industry. He was first appointed as Medical Device Director at 3M Healthcare in France, then Vice President Europe in Brussels.
Alain then served as a strategy consultant for several small- and medium- sized companies. In 1994, he joined Zimmer Inc., where he was appointed CEO in France and was promoted to VP Europe in 1997.
In 2001, he was back to consultancy for orthopedic firms before creating Graftys in 2005.



•     Aurélien Valet, Chairman

•     Alain Tornier, private investor and entrepreneur in medtech

•     Gilles Alberici

•     Alain Valet

•     Philippe Dubrou, private investor and entrepreneur

•     Bruno Paglia, ACG Group


•     OREO finance


•     ACG management

•     Ventech

•     Financière Mirabel

•     Praxis

•     Graft’Invest holding (minority investors, employees, love money)